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In recent years there has been increasing interest in the use of plasminogen 
as  a  potential therapeutic agent in  the  treatment of thrombotic disorders. 
Much work has been  done on the isolation  (1-5),  mechanism of activation 
(6-9),  characterization (10), and development of assay methods (11-13),  for 
the components of the fibrinolytic system. Two assay methods are generally 
used. One measures  the proteolytic activity of the active enzyme on a casein 
substmte; the other the lysis of a fibrin clot produced with a standard amount 
of bovine fibrinogen.  Unfortunately bovine fibrinogen is reported to be con- 
taminated with bovine plasminogen  (14), and interpretation of assay results 
always requires  examination of the role this contaminant could have played 
in determining the rate  of clot lysis.  A  "human plasminogen" preparation 
contains two,  at this time, inseparable  substances--proactivator and proen- 
zyme (plasminogen). The best known activator is streptokinase. Streptokinase 
converts proactivator  to  activator,  which  in  turn  converts  the  proenzyme 
plasminogen  to the active enzyme plasmln.  Plasmin can then be assayed by 
the proteolytic or fibrinolytic method. The rate of casein digestion is relatively 
low, but a tremendous amount of fibrin can be lysed by the enzyme in a very 
short time. The high fibrinolytic activity has been thought to be due to acti- 
vation by the human activator of the bovine plasmlnogen  contaminating the 
bovine  fibrinogen  substrate  (14). Our  calculations  have  revealed  that  the 
amount of bovine plasminogen  that would have to be present as a  contami- 
nant to account for this activity is greater than the amount of bovine fibrino- 
gen present in the assay system. In addition, there are reports of the great 
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fibrinolytic activity of strepto~ctivated  human  plasmin,  ~  with 
a  low fibrinogenolytic activity,  whereas  bovine piasmin exhibits  comparable 
fibrinolytic and fibrinogenolytic activity (15).  Some authors  have attributed 
the difference in fibrinolytic and fibrinogenolytic activity to a  potentiation of 
human  piasmin  activation in  the  dotting  process  (16).  These puzzling  and 
contradictory reports in the literature on any measurement when clotting has 
occurred prompted our investigation of the role of thrombin in  the plasmin 
assay systems.  It was  soon  apparent  that  the  thrombin  preparation  was  a 
key factor in these anomalous results, and we are reporting here the observa- 
tions  which  led  to  this  conclusion.  Moreover,  we have isolated from bovine 
thrombin  preparations  the  factor  responsible  for  the  confusion  and  have 
shown  it  to be similar in physical and  enzymatic properties to bovine pias- 
minogen. 
Materials and Methods 
Fibrinopeptide.----One ml. of normal oxalated human plasma was diluted to 10 ml. 
with water, 2 ml. of 0.1  ~  CaCIj was added, and the mixture dotted with 0.2 ml. 
(100 N.I.H. units) of thrombin. After 30 minutes the clot was spun out on a glass rod 
and the supemate placed in a  23/32  inch Visking  sausage casing.  The casing  was 
immersed in 5 ml. of phosphate buffer (0.1 5, pH 7.4) in a  20 ml. vial and rocked 
at 4  ° for 24 hours. The dialysate should contain the same concentration of the di- 
alyzable fibrinopeptide as the contents of the dialyzed bag. 
Throrabin. -Parke, Davis and Co., Detroit, thrombin topical was used in all as- 
says unless  otherwise stated. A highly purified thrombin prepared by Dr. Walter H. 
Seegers  was used in a  single assay, as was a  commercial Upjohn preparation. The 
commercial preparations were dissolved  at a  concentration of 500 units/ml, of sa- 
line. One rag. of the purified Seegers  preparation was dissolved  in 1 ml. of saline. 
Bovine Fibrinogen.--(Armour  and Company Laboratories, Chicago).  A  1 per cent 
solution in veronal buffer was used in the fibrinolytic assays. 
Veronal Buffer.--4.12  gin. of sodium barbital per liter adjusted  to pI-I 7.4 with 
sodium hydroxide. 
Streptoklnase  (Varidase.--Lederle  Laboratories,  Pearl  RiVer,  New  York).- 
100,000 units  streptokinase and  25,000 units  streptodornase were dissolved  in  10 
ml. of saline. 
Bovine Plasrninogen.--Bovine plasmin0gen  was obtained through  the courtesy of 
Dr. E. Loomis of Parke, Davis and Co, 
Human  Plasminogcn.--Human  plasminogen prepared by a  modification  (17) of 
the Kline method (18) was obtained from the Merck,  Sharp  and Dohme Research 
Laboratories, West Point, Pennsylvania.  35 mg.  was  dissolved  in  95  ml.  of water 
and adjusted to neutral pH by the rapid addition of 5 ml. of 2 M PhOsphate buffer. 
Human  Fibrinegen.--Human  fibrinogen  was  prepared  from a  p0ol  of  oxalated 
normal human plasma by the method of Ware, Guest, and Seegers (19). 
Casein.--A  1.8 per cent solution of casein  in pit  7.4 phosphate buffer was pre- 
pared by the method of Mullertz (6), and stored frozen in small bottles. M.  SIEGEL AND E° E.  CLIlrFTON  379 
Potato Starch.--Powdered Maine potato starch was freed of ultraviolet-adsorbing 
impurities by washing each pound with 1 liter of 0.01 ~  acetic acid at 50  °, removing 
the acid by many distilled water washes, washing with phosphate buffer, water, al- 
cohol, ether, and air drying. 
Radioiodine.--Iodine-131 was obtained  through the generosity of the Oak Ridge 
Laboratories of the Atomic Energy Commission. 0.5 inc. of the carrier-free isotope 
was used to label the proteolytic enhancing factor isolated from commercial throm- 
bin. 
Methods 
Fibrinolytic Assay.--The method previously reported  (2)  has  been used.  In the 
determination of the effect of fibrinopeptide on fibrinolytic activity, 0.4 ml. of the 
fibrinopeptide dialysate was added to a  mixture of 0.035  rag. of "human plasmino- 
gen,"  1000 units of streptokinase (SK), 0.15  ml. of 1 per cent bovine plasminogen, 
and 0.15  ml. of veronal buffer. In assays to determine  the effect of the amount of 
thrombin, the fibrinopeptide was replaced by 0.4 ml: of veronal buffer. In all assays 
the volume of thrombin solution used for dotting was 0.1  ml., and  the amount of 
thrombin used was varied by dilutions with veronal buffer. In assays in which hu- 
man fibrinogen was used as a substrate, 0.15 ml. was used. In determining the "hu- 
man plasminogen"-lysis time curve of Fig. 5, 1000 units of streptokinase were placed 
in each  tube  and varying dilutions  of plasminogen solution added for a  3  minute 
activation period prior to the addition of 0..15 ml. of bovine fibrinogen and sufficient 
veronal buffer to bring the volume to 0.9 nil.  Clotting was accomplished with  50 
units of thrombin. 
Proteolytic Assay.raThe proteoIytic assay method was a previously reported varia, 
tion  (7)  of the method of MuUertz  (6).  When thrombin was present in the assay 
system, it was added just prior to the addition of the final reactant,  casein.  Since 
activation of plasminogen preparations with streptokinase is very rapid, there is no 
effect of varying the order of addition of the reagents. In the determination of pro- 
teolytic activity in the presence of thrombin in which streptokinase  concentration 
was varied,  3.0 ml. of casein solution was added  to 3.0 ml.  of a  phosphate buffer 
solution containing 250 units of thrombin,  0.52  rag. of "human plasminogen," and 
0 to 5000 units of streptokinase.  The mixtures were incubated for 4 hours, and the 
results are reported as the ~/of tyrosine liberated in this time (Fig.  1). The proteo- 
lyric enhancing activity of the starch electrophoresis eluates  were determined  sim- 
ilarly. Either 2 ml. of each eluate was added to 1 ml. of phosphate buffer, or 1 ml. 
of eluate was added to 2 ml. of buffer containing 0.35 rag. of "human plasminogen" 
and 150 units of streptokinase. After the addition of 3.0 ml. of casein 2 minute and 
4  hour samples  were assayed for tyrosine. Spontaneous proteolytic activities  were 
also determined on the eluates by a similar assay replacing the 1 ml. of plasminogen 
and streptokinase by 1 ml. of phosphate buffer. 
In the experiment in which proteolytic activity was measured in the absence and 
presence of bovine fibrinogen, the same amount of "human plasminogen" was used 
as above, and either 1.5 rnl. of phosphate buffer or 1.5 ml. of 1 per cent fibrinogen 
was added.  The  "human plasminogen" was pre-activated  with  0  to 3600 units  of 380  THE  ROLE  OF  A  CONTAMINANT  IN  THROMBIN 
streptokinase/mg.,  and a  0.1  ml. portion of the activated mixture was used for rio 
brinolytic determination.  (Fig. 4) 
Starch  Electrophoresis.--Starch  electrophoresis  of the  thrombin  preparation  and 
of the bovine plasminogen was carried out for 17 hours at 4 ° on a 40 cm. starch block 
of 1 cm. thickness and 19 cm. width. A pH 7.6 phosphate buffer  =  0.  was used 
with filter paper strips connecting the starch block to the electrode vessels.  Approx- 
imately 50 ma. were drawn at a potential difference between the platinum electrodes 
of 400 volts. 5000 units of thrombin were dissolved in 3 ml. of water and dialyzed 
for 2 hours against a portion of the electrophoresis buffer. A 0.5 can. section was cut 
out of the  center  of the  starch  block and  the hole  filled  with a  dry paste  of the 
dialyzed  thrombin  solution and starch. The starch block was allowed to equilibrate 
for 1 hour with the buffer in  the electrode vessels before the current was turned on. 
At the completion of electrophoresis the block was cut into sections of 1 an. width 
and  the protein  ehted  by transferring  the section  to a  sintered  glass funnel  and 
stirring with 5 ml. of saline.  The concentration of protein ehted from each centimeter 
section of the starch block was estimated by measuring the optical density at 275 
mtt of the eluate in  1 an. cuvettes in a  Beckman spectrophotometer. Other assays 
were then carried out on the ehate. Starch electrophoresis of 60 rag. of bovine plas- 
minogen and of a  mixture of 30 nag. of bovine plasminogen and the radioiodinated 
plasmin-enhancing  factor from thrombin  were carried  out similarly.  Radioactivity 
was measured in a ~, weU counter using a filter which diminished activity by a factor 
of 32.8. 
Clotting Time.--A 0.1 ml. portion of the starch electrophoresis ehates was blown 
into a  solution of 0.15 ml. bovine fibrinogen in 0.75 ml. of veronal buffer in a  13  X 
100 mm. test tube, and the tube gently tilted until clotting occurred. 
Radioiodination  of the Thrombin  Contamina~t.--The  starch  electrophoresis  eluate 
containing the proteolytic activity enhancing factor was lyophilized and  iodinated 
with I m  according to the method of Pressman and Eisen  (20). 
RESULTS  AND  DISCUSSION 
Fibrinopeptide.--If  one is to accept the view of Bastian  and Hill  (16)  that 
the process of clotting accelerated the activation of plasminogen with strepto- 
kinase,  then  some substance  formed during  the  clotting process must  be re- 
sponsible for this  acceleration.  The peptide  separated  from fibrinogen by the 
action of thrombin might reasonably be expected to be that substance. When 
fibrinopeptide dialysate was added to the fibrinolytic assay system containing 
human  plasminogen  and  streptokinase,  and  the  mixture  clotted  with  a  ~o 
thrombin  dilution  (1  unit);  a  lysis  time  of 8  minutes  was  observed.  In  the 
absence  of the fibrinopeptide  the  clot also  lysed in 8  minutes.  The presence 
of the  additional  fibrinopeptide  therefore  had  no  effect  on  the  rate  of lysis. 
However, if the same mixture was clotted with undiluted thrombin (50 units) 
a  lysis time of 2.5 minutes was observed.  Since the fibrinopeptide is obtained 
from the breakdown of fibrinogen and the fibrinogen content of the two assay M.  SIEGEL  AND  E.  ~E.  CLI:F~'TON  381 
systems  remains  unchanged,  it  is  difficult  to  see  how  more  fibrinopeptide 
would be formed in  the presence of excess thrombin or indeed how fibrino- 
peptide could be involved. 
Fibrinolytic Activity  of Fibrinolytic Systems Clotted  with  Varying Concentra- 
tions  of  Thrombin.--The  discordant  lytic activities  observed  above  at  two 
different thrombin levels suggested that thrombin concentration might have 
a  determining  role in  fibrinolytic assay.  Five different thrombin  concentra- 
TABLE I 
Fibrinolytic Activity of Plasmin Clotted with Varying Amounts of Thrombin 
Units ofthrombin  Lysis time 
50 
5 
2 
1 
0.5 
mln. 
2.5 
5 
7.5 
8 
10.5 
TABLE II 
Proteolytic Activity of Pla,~nin 
tyrosine 
4 hours 
(1) 250 units thrombin 
(2) 0.52 nag. "human plasminogen" plus 1000 units SK 
(3) 250 units thrombin and 0.52 nag. "human plasminogen"  and 1000 
units SK 
(4) 250 units thrombin and 0.52 rag. "human plasminogen" 
(5) 0.52 rag. human pla~mlnogen 
(6)  1000 units SK 
225 
304 
1360 
235 
10 
2 
tions were used for clotting a system con~inlng "human plasmlnogen," strep- 
tokinase,  and iibrinogen. The results are shown in Table I.  High  thrombin 
concentrations  yielded  rapid  lysis, low  thrombin  concentrations  gave  slow 
lysis. The more thrombin used in  clotting the more fibrinolytic enzyme ap- 
peared to be present to lyse the clot. This 'was' the first positive evidence that 
it was not the dotting process itself, but rather some property of the throm-  i 
bin preparation that was responsible for the acceleration of lysis. 
Seegers' highly purified thrombin at concentrations o1 0.1, 0.01, and 0.001 
per cent were used to dot the same mixture of human plasminogen, strepto- 
kinase, and bovine fibrinogen. Lysis times of 9, 9, and 10 minutes respectively 
were observed. The purified thrombin clotted this mixture as rapidly as the 
Parke, Davis preparation yet it failed to produce the same rapid lysis. Since ,382  THE  ROLE  OF  A  CONTAMITqAIqT  IN  THROMBIN 
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the high thrombin concentration was not responsible for the increase in lysis 
rate, then there must be some component in the commercial  thrombin prepa- 
ration which is not thrombin, and which can contribute to plasmin activity. 
Fibrinolyti¢ Activity  of Human  Fibrinogen and  Streptokinase  Clotted with 
Thrombin.--Human  fibrinogen  containing  added  streptokinase  and  clotted 
with  1 unit of thrombin required more than  2 hours for lysis.  When dotted 
with  50 units  of thrombin,  lysis occurred  in  15  minutes. Human  fibrinogen 
prepared  by the method  of Ware,  Guest,  and  Seegers  under  the  action  of 
streptokinase contains no fibrinogenolytic activity. It is therefore free of both 
proactivator and  proenzyme together but it may contain  one or the other. 
When  1 unit of thrombin  is added for clotting no lysis occurs.  However, 50 
units of thrombin supplies sufficient  quantity of one of the fibrinolytic com- 
ponents missing  from the human fibrinogen  for lysis to occur in  15 minutes. 
If hnman  fibrinogen  contains proactivator,  then  the proenzyme  is  supplied 
by the high concentration of thrombin. If the human fibrinogen  contains pro- 
enzyme, then the high  concentration of thrombin must supply proactivator. 
However, the latter  possibility must be ruled  out since  the  thrombin  is of 
bovine origin  and bovine proactivator is not converted to activator by strep- 
tokinase. 
Proteolyti¢ Activity of Human Plasminogen and Streptokinase in the Presence 
of  Thrombin.--The  tyrosine produced  in  4  hours  by the  action  of various 
enzyme and enzyme mixtures is reported in Table H. The sum of the tyrosine 
liberated by (a) thrombin alone,  and by (b) human plasminogen  together with 
streptokinase  is far less than  that  liberated by (c)  a  mixture  of  thrombin, 
human  plasminogen,  and streptokinase.  In  this  system which  contained  no 
fibrinogen  and in which no dotting has occurred, there was a marked enhance- 
ment of the proteolytic activity of plasmin in the presence of thrombin. These 
results were of such great interest that the experiment reported in Fig. 1 was 
set up. Less than  30 units  of streptokinase  activated enough of the human 
proactivator to convert all of the human proenzyme to plasmin,  and  in  the 
absence of thrombin a  maximum plateau in the proteolytic activity was ob- 
served.  Further  additions of streptokinase  could bring  about no increase in 
proteolytic activity since all  the proenzyme had  already been converted  to 
active plasmin.  In  the  proteolytic assay to  which  thrombin  had  also been 
added, proteolytic activity increased as streptokinase concentration increased, 
and was still increasing  at 5000 units of streptokinase, a level at which inhibi- 
tion begins to appear in the absence of thrombin (21). 
Since  the human  plasmin  content  of the proteolytic system remains  con- 
stant after the addition of 30 units of streptokinase, there must be some other 
substance  present  which  can  combine  with  increasing  amounts  of  strepto- 
kinase and bring about the increased activity observed in the presence of the 
thrombin  preparation.  In a  previous report  (7)  it was shown  that  "human 384  TItE  ROLE  O~  A  CONTAMYNANT IN  TItROM'BIN 
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plasminogen" contains a  large  excess of proactivator. On conversion  to acti- 
vator it can bring about the activation of plasminogen  of human or bovine 
origin. If the thrombin preparation which is of bovine origin contains a large 
amount of bovine  plasminogen  as impurity, then the results of Fig.  1 could 
be anticipated. To confirm this explanation of the enhanced proteolytic ac- 
tivity of human plasmin in the presence of thrombin, electrophoretic  investi- 
gation of the thrombin preparation was undertaken. It is to be noted that 
thrombin itself has some caseinolytic  activity, but this is a  property of the 
enzyme itself and is independent of any added streptokinase.  At 1.4 units of 
streptokinase/mg,  plasminogen,  the  proteolytic activity of  (thrombin  plus 
plasminogen  plus  streptokinase)  is  less than  that  of  the  sum  of  thrombin 
alone and  (plasminogen  plus streptokinase)  alone.  This is probably due  to 
the presence of a small amount of plasmin inhibitor in the thrombin prepara- 
tion. 
Starch Elearopkoresis of Tkrombin Preparations.--Fig. 2 shows the results 
of the starch electrophoresis.  The protein curve shows the presence  of three 
peaks at 5,  8.5, and 12.5 cm.  The thrombin preparation was placed on the 
block at the 7 cm. mark. The bulk of the protein moved toward the anode. 
The rapidly moving peak at the 12.5 cm. coincided with the peak in clotting 
activity. This must be the thrombin peak.  At 8.5  cm.  a  peak was observed 
in proteolytic enhancing activity. This must be the bovine plasminogen peak. 
The small peak at 5 cm. of material moving toward the cathode is the small 
amount of plasmin inhibitor. The low peak at 12.5 cm. of eluate with spon- 
taneous proteolytic activity (or activity in the absence of "human plasmino- 
gen" and streptokinase)  is due to the caseinolytic activity of pure thrombin, 
and accounts for the activity observed in Fig. 1 when 0 units of streptokinase 
was added to the thrombin and plasminogen  mixture. 0.1  ml. of the 9  cm. 
and 0.1  ml.  of the  14 cm.  eluate were used for clotting a  fibrinolytic assay 
system, each containing the same  amount of fibrinogen,  "human plasmino- 
gen," and streptokinase.  These eluates were  chosen because  each contained 
nearly the same units of thrombin as demonstrated by clotting time, but the 
9 cm. material was rich in proteolytic enhancing  factor while the 14 cm. one 
was practically devoid of it. The tube clotted with the 9 cm. material lysed 
in 5.5  minutes; that clotted with the 14 cm. material lysed in 10.5 minutes. 
Therefore,  the proteolytic enhancing  material is also a fibrinolytic enhancing 
material--both  of  which  are  activities associated  with  the  active  enzyme 
plasmin.  All the enzymatic evidence points to the contaminant in thrombin 
as being identical with bovine plasminogen. A further electrophoretic  investi- 
gation was undertaken to show their identity. 
Electropkoresis of Radioiodinated  Enkandng Factor.--Figs. 3 A and 3 B show 
the results of the starch electrophoresis  of bovine plasminogen and of bovine 
plasminogen  to which the radioiodinated plasmin-enhancing factor separated 386  THE  ROLE  OF  A  CONTAMINANT  IN  THROMBIN 
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from thrombin has  been  added.  The  bovine  plasminogen  was  not  electro- 
phoretically homogeneous, and shows two bumps,  as well as a  peak, on the 
protein curve.  (Fig. 3 A) The bulk of the protein scarcely moved in the elec- 
trophoretic field, but the bumps at 9 and 11  cm. suggest  the presence  of at 
least two other components.  Since there is a sharp peak in proteolytic activity 
at 9 cm.  the material responsible for the bump here on the protein curve is 
likely to be the bovine plasminogen. The low specific activity of bovine plas- 
minogen is understandable in view of the large amount of inert protein which 
makes up most of the bovine plasminogen preparation. In Fig. 3 B, in which 
5  rag.  of iodinated plasmin-enhancing factor separated from thrombin was 
mixed with 30 mg. of bovine plasminogen  before electrophoresis  of the mix- 
ture,  the proteolytic activity peak again appeared at 9  cm.,  and coincided 
exactly with  the  peak  in  radioactivity. Therefore,  radioiodinated plasmin- 
enhancing factor from thrombin behaves electrophoretically  exactly as does 
bovine plasminogen.  The location of the proteolytic activity peak at 9  cm. 
in the electrophoretic  curves  of both the bovine plasminogen  alone, and bo- 
vine plasminogen  plus plasmin-enhancing factor makes it unlikely that the 
coincidence of the radioactivity and proteolytic activity peaks  of  Fig.  3  B 
is  due  to  a  complex  formation between bovine plasminogen  and  iodirmted 
plasmin-enhancing factor.  Indeed,  it  is  strong  evidence  that  the  two  sub- 
stances are identical. 
Plasminogen Content of Fibrinolytic Assay Systems.--The experiment  re- 
ported in Fig. 4 was set up to measure the proteolytic activity of the bovine 
plasminogen contaminant in a commerical bovine fibrinogen preparation. The 
same relative amounts of "human plasminogen" and fibrinogen were used in 
the proteolytic test as were used in the fibrinolytic  test. The proteolytic ac- 
tivity of a mixture of "human plasminogen" and streptokinase on casein alone 
is  shown  on  curve A,  the proteolytic activity on  casein  containing bovine 
fibrinogen  on curve  B, and the fibrinolytic activity (fibrinogen  clotted with 
50 units of thrombin) on curve C. The proteolytic activity in the presence of 
bovine fibrinogen  is  only slightly higher  than that  on  casein  alone  at  low 
streptokinase  concentrations and  reaches  a  maximum value which  is  only 
twice as great as that of curve A at high streptokinase concentrations.  This 
indicated that the proteolytic activity due to  the bovine  plasminogen  con- 
taminant of fibrinogen is just about equal in value to the proteolytic activity 
of the human plasmin alone.  At 36 units of streptokinase the total (human 
plus bovine) plasmin activity is 400 3' tyrosine/4 hours. At 1000 units of strep- 
tokinase, it is 600. Proteolytic activity increased  only 50 per cent; yet over 
that same streptokinase range the lysis time dropped  from 15 minutes to 3.5 
minutes. According  to  Fig.  5  this  represents  a  26-fold increase  in plasmin 
fibrinolytic activity. Bovine fibrinogen  appears to contain small  amounts of 
bovine  plasminogen  in  the  proteolytic  test,  yet  tremendous  amounts  are 390  THE  ROLE  OF  A  CONTAMINANT  IN THROMBIN 
present  in  the fibrinolytic test.  The  fibrinolytic test  contains  the one addi- 
tional reagent,  thrombin, which is missing from the proteolytic test, and it is 
this which contains the bulk of the bovine plasmlnogen.  In Fig. 1 the relative 
amount  of thrombin  to  human  plasminogen  plus  streptokinase  is only one- 
third  of  the amount  in  the fibrinolytic test,  and  yet seven times as much 
fibrinolytic activity is observed in the presence of thrombin as in its absence 
at high streptokinase concentrations. At three times this thrombin concentra- 
tion  (the relative amounts in the fibrinolytic test)  there would be a  21-fold 
increase in plasmin proteolytic activity. This is in good agreement with the 
26-fold  increase observed in fibrinolytic activity when 50 units  of thrombin 
are used for clotting. 
Reevaluation of Fibrinolytic Activities.--Interpretation of much of the work 
in  the  literature  on  the  components of  the fibrinolytic system is  based on 
measurements of fibrinolytic activity. When this activity has been measured 
on systems containing  human plasma fraction and  streptokinase  the role of 
the thrombin contaminant  can be of prime significance.  Until measurements 
can be repeated on fibrin substrates free of a bovine plasminogen contaminant 
in  thrombin  the claims  from this  laboratory (2)  that  plasmln  is "primarily 
fibrinolytic rather  than  proteolytic when compared  with  trypsin"  and  that 
soy bean inhibitor fails to inhibit plasmln fibrinolytic activity must be with- 
drawn. A few papers (14-15) have ~eemed puzzling  to us, and introduction of 
bovine plasmlnogen could account fox" the results which did not fit in with our 
general concept of the plasmin system. 
Alternate interpretations could be advanced for many other papers appear- 
ing in the literature. It is to be hoped that investigators in this feld will keep 
in mind  that  any experiment  in  which bovine thrombin  has  been used for 
clotting  is  an  experiment  which  must  be closely examined  to  see whether 
large amounts of bovine plasminogen fortuitously added could be responsible 
for the observed results. 
SUMMARY 
Many of the anomalous results obtained in the fibrinolytic assay of human 
plasmin  systems were shown  to be simply explained  if bovine plasminogen 
had been introduced into the assay system on the addition of thrombin. Ex- 
perimental  investigation  of  the proteolytic and  fibrinolytic activity of sys- 
tems  containing  plasmln  and  thrombin  showed  that  enzyme  activity  was 
influenced  by the presence and quantity of thrombin. The quantity of bovine 
plasminogen present as a  contaminant  in bovine fibrinogen  was shown to be 
responsible for only ~,~sth  of the observed enhanced  activity. Thrombin  in 
the amounts  commonly used for clotting  contained  sufficient  proenzyme to 
account for all this activity. A highly purified thrombin preparation obtained 
from another laboratory, and  thrombin purified  in this laboratory by starch M. SIEGEL AND E. E. CLIFFTON  391 
electrophoresis  brought  about  no  enhancement  of  activity.  The  material 
separated from thrombin by starch electrophoresis was shown to be enzymat- 
ically identical with bovine plasminogen and,  on labelling with radioactive 
iodine,  was  shown  to  behave  physically like  bovine  plasminogen.  Several 
experiments reported in the literature were reinterpreted in the light of this 
observation. 
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